Novo Jennifer, Seth Ishith, Mon Yi, Soni Akshay, Elkington Olivia, Marcaccini Gianluca, Rozen Warren M
Faculty of Medicine and Surgery, University of Notre Dame, Sydney, NSW 2008, Australia.
Department of Plastic and Reconstructive Surgery, Peninsula Health, Melbourne, VIC 3199, Australia.
Biomimetics (Basel). 2025 Feb 9;10(2):97. doi: 10.3390/biomimetics10020097.
BACKGROUND/OBJECTIVES: Robotic systems offer enhanced precision, dexterity, and visualization, which are essential in addressing the complex nature of plastic surgery procedures. Despite widespread adoption in other surgical specialties, such as urology and gynecology, their application in plastic surgery remains underexplored. This review examines the use of robotic systems in plastic and reconstructive surgery with a focus on clinical outcomes.
A literature search was conducted using PubMed, Embase, Scopus, and Web of Science. Search terms included ("robotic surgery" OR "surgical robots") AND ("plastic surgery" OR "reconstructive surgery"). Studies on clinical outcomes and biomimetic innovations published between 1980 and 2024 were included, while non-English, cadaver-based, and animal studies were excluded. Data were systematically extracted using Covidence and analyzed.
Twenty-nine studies were identified that evaluated the clinical outcomes of robotics in areas including breast reconstruction, microsurgery, and craniofacial procedures. Robotic systems like the Da Vinci and Symani platforms offer motion scaling, tremor elimination, and enhanced depth perception. In nipple-sparing mastectomies, they reduced skin necrosis rates from 8% to 2%, while in DIEP flap reconstruction, they enabled smaller fascial incisions (2.67 ± 1.13 cm vs. 8.14 ± 1.69 cm) and faster recovery with fewer complications. In microsurgery, they achieved 100% patency for vessels under 0.3 mm and a 25.2% limb volume reduction in lymphedema patients in 3 months.
Robotic systems show significant promise, particularly in procedures such as nipple-sparing mastectomies, and have the potential to overcome challenges including surgeon fatigue. However, challenges such as longer operating times, high costs, and limited haptic feedback remain barriers to their adoption.
背景/目的:机器人系统具有更高的精准度、灵活性和可视化效果,这对于应对整形手术的复杂性至关重要。尽管机器人系统在泌尿外科和妇科等其他外科专科中已广泛应用,但其在整形手术中的应用仍有待深入探索。本综述探讨了机器人系统在整形和重建手术中的应用,重点关注临床结果。
使用PubMed、Embase、Scopus和Web of Science进行文献检索。检索词包括(“机器人手术”或“手术机器人”)以及(“整形手术”或“重建手术”)。纳入1980年至2024年间发表的关于临床结果和仿生创新的研究,排除非英文、基于尸体和动物的研究。使用Covidence系统提取数据并进行分析。
共确定了29项评估机器人技术在乳房重建、显微外科和颅面手术等领域临床结果的研究。达芬奇和Symani等机器人系统提供运动缩放、震颤消除和增强的深度感知功能。在保留乳头的乳房切除术中,它们将皮肤坏死率从8%降至2%;在腹壁下动脉穿支皮瓣重建术中,它们使筋膜切口更小(2.67±1.13厘米对8.14±1.69厘米),恢复更快且并发症更少。在显微外科手术中,它们使直径小于0.3毫米的血管通畅率达到100%,并使淋巴水肿患者在3个月内肢体体积减少25.2%。
机器人系统显示出巨大的潜力,特别是在保留乳头的乳房切除术等手术中,并且有潜力克服包括外科医生疲劳在内的挑战。然而,手术时间长、成本高和触觉反馈有限等挑战仍然是其应用的障碍。